(NASDAQ: CDIO) Cardio Diagnostics Holdings's forecast annual revenue growth rate of 3,293.11% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 9,933.27%, and while it is forecast to beat the US market's average forecast revenue growth rate of 1,450.25%.
Cardio Diagnostics Holdings's revenue in 2025 is $15,782.On average, 3 Wall Street analysts forecast CDIO's revenue for 2025 to be $977,850, with the lowest CDIO revenue forecast at $939,503, and the highest CDIO revenue forecast at $1,006,611.
In 2026, CDIO is forecast to generate $46,564,301 in revenue, with the lowest revenue forecast at $44,738,250 and the highest revenue forecast at $47,933,839.